FDA Clears Simbionix Rehearsal Studio Software

September 29, 2010—Simbionix Ltd. (Cleveland, OH) announced the receipt of US Food and Drug Administration clearance for the Procedure Rehearsal Studio software. The product is intended for use as a software interface and image segmentation system for the transfer of imaging data from a medical scanner such as a computed tomographic scanner to an output file. It is also intended as preoperative software for simulating and evaluating surgical treatment options. The company's three-dimensional segmentation model can be exported to the Simbionix Angio Mentor simulator practice environment. The results are an advanced method of creating an ever-expanding library of modules for training and postoperative debriefing.